Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

ErbB2 expression through heterodimerization with erbB1 is necessary for ionizing radiation- but not EGF-induced activation of Akt survival pathway.

Toulany M, Minjgee M, Kehlbach R, Chen J, Baumann M, Rodemann HP.

Radiother Oncol. 2010 Nov;97(2):338-45. doi: 10.1016/j.radonc.2010.03.008. Epub 2010 Mar 27.

PMID:
20347166
2.

Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.

Maegawa M, Takeuchi K, Funakoshi E, Kawasaki K, Nishio K, Shimizu N, Ito F.

Mol Cancer Res. 2007 Apr;5(4):393-401.

3.

Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.

Deb TB, Su L, Wong L, Bonvini E, Wells A, David M, Johnson GR.

J Biol Chem. 2001 May 4;276(18):15554-60. Epub 2001 Feb 5.

4.

Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation.

Toulany M, Schickfluss TA, Fattah KR, Lee KJ, Chen BP, Fehrenbacher B, Schaller M, Chen DJ, Rodemann HP.

Radiother Oncol. 2011 Oct;101(1):140-6. doi: 10.1016/j.radonc.2011.06.004. Epub 2011 Jun 30.

PMID:
21723633
7.

Macrophage inhibitory cytokine-1 activates AKT and ERK-1/2 via the transactivation of ErbB2 in human breast and gastric cancer cells.

Kim KK, Lee JJ, Yang Y, You KH, Lee JH.

Carcinogenesis. 2008 Apr;29(4):704-12. doi: 10.1093/carcin/bgn031. Epub 2008 Feb 6.

PMID:
18258606
8.

Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.

Gan Y, Shi C, Inge L, Hibner M, Balducci J, Huang Y.

Oncogene. 2010 Sep 2;29(35):4947-58. doi: 10.1038/onc.2010.240. Epub 2010 Jun 21.

PMID:
20562913
9.

Blockade of EGFR and ErbB2 by the novel dual EGFR and ErbB2 tyrosine kinase inhibitor GW572016 sensitizes human colon carcinoma GEO cells to apoptosis.

Zhou Y, Li S, Hu YP, Wang J, Hauser J, Conway AN, Vinci MA, Humphrey L, Zborowska E, Willson JK, Brattain MG.

Cancer Res. 2006 Jan 1;66(1):404-11.

10.

Cyclic stretch activates p38 SAPK2-, ErbB2-, and AT1-dependent signaling in bladder smooth muscle cells.

Nguyen HT, Adam RM, Bride SH, Park JM, Peters CA, Freeman MR.

Am J Physiol Cell Physiol. 2000 Oct;279(4):C1155-67.

11.

Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells.

Grunt TW, Wagner R, Grusch M, Berger W, Singer CF, Marian B, Zielinski CC, Lupu R.

Biochem Biophys Res Commun. 2009 Jul 31;385(3):454-9. doi: 10.1016/j.bbrc.2009.05.085. Epub 2009 May 23.

PMID:
19467222
12.

Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns.

Wosikowski K, Schuurhuis D, Johnson K, Paull KD, Myers TG, Weinstein JN, Bates SE.

J Natl Cancer Inst. 1997 Oct 15;89(20):1505-15.

PMID:
9337347
14.
15.

p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal.

Diehl KM, Grewal N, Ethier SP, Woods-Ignatoski KM.

J Surg Res. 2007 Sep;142(1):162-9. Epub 2007 Jul 5.

PMID:
17612563
16.

PI3K-Akt signaling regulates basal, but MAP-kinase signaling regulates radiation-induced XRCC1 expression in human tumor cells in vitro.

Toulany M, Dittmann K, Fehrenbacher B, Schaller M, Baumann M, Rodemann HP.

DNA Repair (Amst). 2008 Oct 1;7(10):1746-56. doi: 10.1016/j.dnarep.2008.06.017. Epub 2008 Aug 22.

PMID:
18678286
18.
19.

p38 and EGF receptor kinase-mediated activation of the phosphatidylinositol 3-kinase/Akt pathway is required for Zn2+-induced cyclooxygenase-2 expression.

Wu W, Silbajoris RA, Whang YE, Graves LM, Bromberg PA, Samet JM.

Am J Physiol Lung Cell Mol Physiol. 2005 Nov;289(5):L883-9. Epub 2005 Jun 24.

20.

Radiotherapy-induced signal transduction.

Yacoub A, Miller A, Caron RW, Qiao L, Curiel DA, Fisher PB, Hagan MP, Grant S, Dent P.

Endocr Relat Cancer. 2006 Dec;13 Suppl 1:S99-114.

Supplemental Content

Support Center